Impact Factor 4.400

The 1st most cited open-access journal in Pharmacology & Pharmacy

General Commentary ARTICLE

Front. Pharmacol., 10 March 2015 | https://doi.org/10.3389/fphar.2015.00023

Corrigendum: Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions

  • Pharmacognosy, School of Pharmacy, University College London, London, UK

A corrigendum on
Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions

by Mazzari, A. L. D. A., and Prieto, J. M. (2014). Front. Pharmacol. 5:162. doi: 10.3389/fphar.2014.00162

We noticed that some symbols were lacking in Table 5 and some of the Plant Family names were not currently accepted.

We hereby present the Tables 19 with all symbols and botanical names re-checked.

TABLE 1
www.frontiersin.org

Table 1. Medicinal plant species listed in RENISUS with reported effects of on CYP1A2.

TABLE 2
www.frontiersin.org

Table 2. Medicinal plant species listed in RENISUS with reported effects of on CYP2C9.

TABLE 3
www.frontiersin.org

Table 3. Medicinal plant species listed in RENISUS with reported effects of on CYP2C19.

TABLE 4
www.frontiersin.org

Table 4. Medicinal plant species listed in RENISUS with reported effects of on CYP2D6.

TABLE 5
www.frontiersin.org

Table 5. Medicinal plant species listed in RENISUS with reported effects of on CYP2E1.

TABLE 6
www.frontiersin.org

Table 6. Medicinal plant species listed in RENISUS with reported effects of on CYP3A.

TABLE 7
www.frontiersin.org

Table 7. Medicinal plant species listed in RENISUS with reported effects of on glutathione levels.

TABLE 8
www.frontiersin.org

Table 8. Medicinal plant species listed in RENISUS with reported effects of on UGT levels.

TABLE 9
www.frontiersin.org

Table 9. Medicinal plant species listed in RENISUS with reported effects of on P-glycoprotein activity.

Apologies for any inconvenience this may have caused.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: herb-drug interactions, cytochrome P450, glutathione, glucuronidation, P-glycoprotein, polymorphism, Brazil, pharmacovigilance

Citation: Mazzari ALDA and Prieto JM (2015) Corrigendum: Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions. Front. Pharmacol. 6:23. doi: 10.3389/fphar.2015.00023

Received: 07 November 2014; Accepted: 27 January 2015;
Published online: 10 March 2015.

Edited by:

Adejuwon Adewale Adeneye, Lagos State University College of Medicine, Nigeria

Reviewed by:

Fang-Rong Chang, Kaohsiung Medical University, Taiwan
Eleni Skaltsa, National and Kapodistrian University of Athens, Greece

Copyright © 2015 Mazzari and Prieto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: j.prieto@ucl.ac.uk